The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
March 18th 2024
In an announcement by Aquestive Therapeutics, these new findings demonstrated the potential of this orally-administered epinephrine treatment.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Community Practice Connections™: Navigating a New Era of Food Allergy Management
View More
“Hookworm Soup†a Potent Asthma Solution?
Hookworms aren't the common affliction that they once were, at least in the developed world, but asthma prevalence is growing. A new study winks at a correlation, suggesting that a protein in the pesky parasites may treat asthma.
Too Many Ways to Measure an Itch, Derm Study Finds
October 12th 2016Dermatitis researchers use far too many instruments in measuring symptoms of skin ailments, a study found. Symptoms of atopic ezcema/dermatitis (AD) were found in a systematic review of randomized controlled trials (RCTs) to be most often characterized from composite measures rather than stand-alone symptom severity rating instruments, and thirty different instruments were found to have been used across 378 trials.
Early Subcutaneous Allergen Immunotherapy Works for Certain Patients
October 12th 2016Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.
Atopic Dermatitis: Immunotherapy Can Be Effective
October 10th 2016Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.
Children with “Hard-to-Control†Asthma Require Specific, Tailored Treatment
Using data from the Inner City Asthma Consortium, researchers from the Ann & Robert H. Lurie Children’s Hospital in Chicago were able to distinguish asthmatic children by the degree to which their condition could be controlled, and to make recommendations for more difficult cases.
Which Patients with Atopic Dermatitis Are Least Likely to Outgrow It?
October 6th 2016Childhood atopic dermatitis (AD) usually resolves before adulthood, a meta-analysis of cases showed. Those patients who did see their AD persist were more likely to be female, to have been older at onset, and to have relatively severe AD.
Assessing Links Between Tobacco Smoke and Atopic Dermatitis
Across the board, researchers saw that studies of active smokers showed increased prevalence of the skin condition, regardless of age or region. It isn't quite clear, though, whether smoking causes AD or AD causes people to smoke.
Allergen Immunotherapy May Prevent Progression of Allergic Rhinitis to Asthma
Allergen immunotherapy can reduce symptoms of allergic rhinitis and asthma and decrease the need for medication, but it poses the risk of asthma exacerbation or anaphylaxis, particularly in patients with uncontrolled asthma.
Asthma Predisposition High Among Children With Food Allergies
The study claims to be “one of the largest primary care cohorts ever assembled to describe epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy.â€